Code Biotherapeutics, Inc. announced it raised $37.5 Million in an initial filing from an offering of $75 Million

Jun 09, 2022•about 3 years ago

Amount Raised

$37.5 Million

HatfieldHealthcare

Company Information

Company

Code Biotherapeutics, Inc.

Location

2801 STERLING DRIVE

Hatfield, Pennsylvania, United States

About

Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases not well served by other gene therapy technologies.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech